Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/35953
Title: | Changes on the health care of people with multiple sclerosis from Latin America during the COVID-19 pandemic | Authors: | Chertcoff, Anibal Bauer, Johana Silva, Berenice Anabel Aldecoa, Mayra Eizaguirre, Maria Barbara Rodriguez, Roberto Chereque, Ana Heudebert, Maria Lourdes Rodriguez Milanesi, Veronica Morales, Lourdes Castellon, Melba Pineda, Suyapa Mejia Ferrandina, Flavia Henestroza, Paula Peraza, Margarita Ruiz Rivas, Fatima Vallecillo Lopez, Lucia Cedeno Herrera, Leticia Sosa, Marta Munoz, Veronica Cruchet Barahona, Ana Silvia Gudino, Luz Maria Ramirez Carballido, Susana Walton, Clare PEETERS, Liesbet Rijke, Nick Garcea, Orlando Carra, Adriana Alonso, Ricardo |
Issue Date: | 2021 | Publisher: | ELSEVIER SCI LTD | Source: | Multiple sclerosis and related disorders (Print), 54 , (Art N° 103120) | Abstract: | Background: The COVID-19 pandemic has resulted in uncertain access to medical treatment for people with multiple sclerosis (pwMS) all over the world. However, there is no data regarding its impact on access to health care of pwMS from Latin America. Objectives: We investigated and described changes in health care delivery for pwMS from Latin America during the COVID-19 pandemic. Methods: PwMS from 18 patient organizations of the region completed a web-based survey hosted from May to October 2020. Results: A total of 602 pwMS completed the questionnaire. Changes in disease-modifying therapies (DMTs) use: 6.7% of pwMS on continuous DMTs claimed to stopped them; 14.1% of those on infusion therapies declared to postpone their dosing; 68.8% declared delaying the initiation of a DMT. Disruptions in accessing rehabilitation services were reported by 65.7%. Changes in laboratory and MRI monitoring were reported by 30% and 33%, respectively. In a multivariable-adjusted logistic regression model, changes in laboratory monitoring were significantly associated with increased odds of postponing MRI monitoring (OR 4.09 CI95% 2.79-6.00, p < 0.001). Conclusions: The COVID-19 pandemic has disrupted all aspects of the routine care for pwMS from Latin America. Consequences are yet to be determined. | Notes: | Chertcoff, A (corresponding author), Esclerosis Multiple Argentina EMA, Uriarte 1465, RA-1414 Buenos Aires, DF, Argentina. achertcoff@hbritanico.com.ar |
Keywords: | Multiple sclerosis;COVID-19 pandemic;Patient-Reported outcomes;Latin america;Health care access | Document URI: | http://hdl.handle.net/1942/35953 | ISSN: | 2211-0348 | e-ISSN: | 2211-0356 | DOI: | 10.1016/j.msard.2021.103120 | ISI #: | WOS:000703619200021 | Rights: | 2021 Elsevier B.V. All rights reserved. | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2022 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1-s2.0-S2211034821003874-main.pdf Restricted Access | Published version | 1.4 MB | Adobe PDF | View/Open Request a copy |
WEB OF SCIENCETM
Citations
9
checked on Sep 28, 2024
Page view(s)
26
checked on Sep 7, 2022
Download(s)
4
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.